Aethlon Medical Inc (AEMD)

[ANESRI]

hotdog1012,

"civilian deaths because of sepsis in 2009 with the number being 215,000 and the associated cost - 16.7B. The goal is to save atleast 43,000 US lives and $3.3B annually"!!! This is from the DARPA DLT presentation.
AEMD has potential blockbuster applications with at least Sepsis and HCV. What surprises me is that Fresenius has not jumped in so far. Fresenius seems to be the one which would capitalize the earliest with AEMD, with the internationally ready infrastructure and the huge R&D they possess. I think that would be a scary scenario to other pharmas.